Table 4.
ART outcomes |
Worries reported at assessment for ART eligibility |
|||||||
---|---|---|---|---|---|---|---|---|
No worry |
One worry or more |
Specific worries |
||||||
|
|
HIV status disclosure |
Nutrition |
Condoms use |
Use of other medication |
ART Adherence |
ART side effects |
|
n=104 | n=195 | n=54 | n=38 | n=23 | n=26 | n=19 | n=19 | |
Total with CD4 counts after ART eligibility |
63 |
134 |
32 |
22 |
14 |
18 |
15 |
11 |
Mean CD4 counts increase (per year) (95% CI) |
162 |
199 |
112 |
127 |
97 |
363 |
189 |
156 |
(112-211) |
(129-270) |
(80-145) |
(87-167) |
(42-151) |
(-19-746) |
(56-322) |
(-31-343) |
|
Median CD4 increase |
92 |
114 |
73 |
112 |
74 |
122 |
115 |
168 |
(IQR) |
(47-212) |
(41-213) |
(41-183) |
(46-215) |
(40-106) |
(59-210) |
(33-232) |
(73-237) |
Total with viral loads |
54 |
126 |
33 |
24 |
14 |
16 |
15 |
12 |
CD4 count > 100 after ART start |
42 (78%) |
95 (75%) |
23 (70%) |
16 (67%) |
10 (71%) |
10 (63%) |
15 (100%) |
12 (100%) |
Annual decrease in median log VL (IQR) |
0.01 |
−0.10* |
−0.24* |
0.04* |
0.18 |
0.17 |
−0.14 |
0.05 |
(-0.10-0.12) |
(-0.19 - -0.02) |
(-0.41 - -0.07) |
(-0.12 - -0.21) |
(0.01-0.35) |
(0.12 - 0.33) |
(-0.49 - 0.20) |
(-0.02 - 0.30) |
|
Number who started ART |
104 |
195 |
51 |
38 |
23 |
24 |
19 |
19 |
Substituted / switched ART |
29 (28%) |
53 (27%) |
16 (31%) |
7 (18%) |
6 (26%) |
8 (33%) |
3 (16%) |
7 (37%) |
Died | 19 (18%) | 13 (7%) | 5 (10%) | 4 (11%) | 1 (4%) | 1 (4%) | 0 (0) | 1 (5%) |
*p<0.05 Note: Comparisons are between those with one or more worries and those with no worry, and also between those with a particular worry and all those without that particular worry.